San Mateo, CA, United States of America

Christopher Robert Bebbington

USPTO Granted Patents = 44 

 

 

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 272(Granted Patents)


Location History:

  • Berkshire, GB (2004 - 2007)
  • Oxford, CA (US) (2007)
  • Newbury, GB (2009)
  • South San Francisco, CA (US) (2006 - 2015)
  • San Mateo, CA (US) (2005 - 2021)
  • San Carlos, CA (US) (2023 - 2024)

Company Filing History:


Years Active: 2004-2024

Loading Chart...
Loading Chart...
Loading Chart...
44 patents (USPTO):Explore Patents

Title: Christopher Robert Bebbington: Innovator in Cancer Treatment

Introduction

Christopher Robert Bebbington is a prominent inventor based in San Mateo, California, known for his significant contributions to cancer treatment through the development of innovative antibody therapies. With an impressive portfolio of 44 patents, Bebbington has dedicated his career to advancing medical science and improving patient outcomes.

Latest Patents

Among his latest inventions are the "Anti-Siglec-7 antibodies having reduced effector function" and "Anti-Siglec-7 antibodies for the treatment of cancer." These patents provide novel methods and compositions that demonstrate potential in treating cancer by utilizing anti-Siglec-7 antibodies, paving the way for transformative therapies in oncology.

Career Highlights

Bebbington has held key positions at notable companies such as KaloBios Pharmaceuticals, Inc. and Medarex, Inc., where he has been instrumental in the development of cutting-edge therapeutic solutions. His extensive experience in biotechnology has made him a critical player in the field of biomedical innovations.

Collaborations

Throughout his career, Bebbington has collaborated with renowned professionals, including Geoffrey T. Yarranton and Susan Mary Kingsman. These partnerships have allowed him to leverage diverse expertise and drive forward-thinking projects that aim to revolutionize cancer treatment.

Conclusion

Christopher Robert Bebbington exemplifies the spirit of innovation in the biomedical field. His dedicated work and substantial patent portfolio reflect his commitment to advancing cancer therapies, showcasing the impact of collaboration and creativity in achieving medical breakthroughs. As he continues to push the boundaries of research, Bebbington remains a pivotal figure in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…